Aldo-keto reductase family 1 member C4 (AKR1C4) activators form a unique class of chemicals known for their role in modulating the activity of the AKR1C4 enzyme, a member of the aldo-keto reductase superfamily. These activators can enhance the enzymatic function of AKR1C4, which is involved in the catalysis of a broad spectrum of substrates, including steroids, prostaglandins, and xenobiotics. The AKR1C4 enzyme plays a pivotal role in the metabolism of various biological compounds, acting primarily as a reductase and converting ketones and aldehydes to their corresponding alcohols. The activators of AKR1C4, therefore, can influence the metabolic pathways in which AKR1C4 is involved by increasing its catalytic efficiency and overall activity.
The chemical structure of AKR1C4 activators is diverse, but they commonly possess functional groups or molecular frameworks that facilitate interaction with the enzyme's active site. This interaction can lead to conformational changes in the enzyme or modify the electron distribution within the active site, thereby enhancing the enzyme's ability to bind and reduce its substrates. Activators may work by stabilizing the enzyme-substrate complex, lowering the activation energy required for the catalytic reaction, or by increasing the enzyme's affinity for its substrates. The specificity and potency of these activators are governed by their chemical structure, and alterations in their molecular configuration can have a significant impact on their ability to activate AKR1C4.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DHEA | 53-43-0 | sc-202573 | 10 g | $111.00 | 3 | |
Another direct substrate, metabolized by AKR1C4 to androstenedione. | ||||||
Cortisone | 53-06-5 | sc-207455 | 5 g | $230.00 | ||
Reduced by AKR1C4 to cortisol. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Indirectly affects AKR1C4 by influencing prostaglandin pathways. | ||||||
Farnesol | 4602-84-0 | sc-204748 sc-204748A | 50 ml 100 ml | $281.00 $374.00 | 2 | |
Influences the mevalonate pathway, potentially affecting steroid synthesis and thereby AKR1C4 activity. | ||||||
all-trans Retinal | 116-31-4 | sc-210778A sc-210778 | 250 mg 1 g | $129.00 $379.00 | 7 | |
Serves as a substrate for AKR1C4, getting reduced to retinol. | ||||||
Linoleic Acid | 60-33-3 | sc-200788 sc-200788A sc-200788B sc-200788C | 100 mg 1 g 5 g 25 g | $34.00 $64.00 $166.00 $281.00 | 4 | |
A fatty acid substrate that can be metabolized by AKR1C4. | ||||||
Caffeic Acid | 331-39-5 | sc-200499 sc-200499A | 1 g 5 g | $32.00 $62.00 | 1 | |
Polyphenol that can influence various cellular pathways, potentially affecting AKR1C4 activity. | ||||||